Science Explorer Interactive view Map
Company · Ústí nad Labem · Czechia

ImunomedicA (Czechia)

imunomedica.czROR OpenAlex
Research works
1
fractional, all time
Citations
75
54.7 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
24%
world 28%

Not ranked overall: ImunomedicA (Czechia) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does ImunomedicA (Czechia) publish most on?

By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses and Immunodeficiency and Autoimmune Disorders.

Monoclonal and Polyclona…0Monoclonal and Polyclonal Antibodies Research: 0 fractional worksImmunotherapy and Immune…0Immunotherapy and Immune Responses: 0 fractional worksImmunodeficiency and Aut…0Immunodeficiency and Autoimmune Disorders: 0 fractional works
Radiology, Nuclear Medicine and ImagingImmunology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  2. 2 Immunotherapy and Immune Responses Immunology 0 works
  3. 3 Immunodeficiency and Autoimmune Disorders Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available24.4%not open75.6%

World: 28% of research is openly available.

with international co-authors57.3%domestic only42.7%

World: 19% is written across borders.

How has ImunomedicA (Czechia)'s research output changed?

20102015

Other research institutions in Ústí nad Labem

All research institutions in Ústí nad Labem

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.